tag:blogger.com,1999:blog-8550428.post3024609386327100625..comments2024-03-27T01:34:23.434-04:00Comments on Pharma Marketing Blog: Regulating DTC for BTCVladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-8550428.post-71664287416971737282007-10-08T11:19:00.000-04:002007-10-08T11:19:00.000-04:00I think Merck also applied for OTC status for Meva...I think Merck also applied for OTC status for Mevacor. Perhaps OTC is too lax, so BTC would be next best.PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-10454931563809987822007-10-08T11:15:00.000-04:002007-10-08T11:15:00.000-04:00Actually, I think that only 1 drug company has pus...Actually, I think that only 1 drug company has pushed to sell statins OTC or BTC--BMS. Unless a product is ready to go LOE, it makes little sense for a drug company to push OTC/DTC. There would be a substantial loss of revenue.Anonymousnoreply@blogger.com